Back to search
Fibrodysplasia Ossificans Progressiva
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrodysplasia Ossificans Progressiva trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fibrodysplasia Ossificans Progressiva trials you may qualify forThe participants in this registry study will have fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare, severely disabling disease characterized b…
The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly…
This is an observational pre-post study to observe if the off label use of anti-IL1 therapies, such as anakinra or canakinumab, can block ACVR1-induced flare ac…
This Phase 2, Randomized, Double-Blind, Placebo-Controlled Study is intended to evaluate the Efficacy, Safety, and Tolerability and PK of INCB000928 administere…
This study is researching an experimental drug called garetosmab, referred to as "study drug". The study is focused on children and adolescent participants with…
Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by the presence of bone in soft tissue where bone normally does…